EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Study of seroprevalence of SARS‐CoV‐2 in Kazakhstan

Mukhtar Kulimbet, Timur Saliev, Gulzhan Alimbekova, Dinara Ospanova, Kundyzay Tobzhanova, Dariga Tanabayeva, Baurzhan Zhussupov, Ildar Fakhradiyev iD

Epidemiology and Infection · 2023

DOI: 10.1017/s0950268823001085 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Epidemiology and Infection, 2023. Verfasst von Mukhtar Kulimbet und 7 weiteren Autor:innen. Beteiligte Einrichtung: B. Atchabarov Scientific-Research Institute of Fundamental and Applied Medicine, S.D. Asfendiyarov Kazakh National Medical University, Almaty, Republ…. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study aimed to analyse the seroprevalence of SARS-CoV-2 in Kazakhstan. This is a cross-sectional study of adult population in Kazakhstan for the period from October 2021 to May 2022. For the study, 6 720 people aged 18 to 69 were recruited (from 17 regions). The demographic data were collected and analysed. Gender was evenly distributed (males 49.9%, females 50.1%). Women exhibited a higher seroprevalence than men (IgM 20.7% vs 17.9% and IgG 46.1% vs 41.5%). The highest prevalence of IgM was found in the age group of 30–39. However, the highest prevalence of IgG was detected in the age group of 60–69. The seroprevalence of IgG increased across all groups (from 39.7% in 18–29 age groups to 53.1% in 60–69 age groups). The odds for a positive test were significantly increased in older age groups 50–59 ( p < 0.0001) and 60–69 ( p < 0.0001). The odds of a positive test were 1.12 times higher in females compared to males ( p = 0.0294). The odds for a positive test were significantly higher in eight regions (Astana, Akmola, Atyrau, Western Kazakhstan region, Kostanai, Turkestan, Eastern Kazakhstan region, and Shymkent) compared to Almaty city. The odds of a positive test were three times higher in Astana and the Western Kazakhstan region than in Almaty city. In urban areas, the odds of a positive test were 0.75 times lower than in rural areas ( p < 0.0001). The study’s results showed an adequate level of seroprevalence (63%) that exceeds the essential minimum of herd immunity indicators in the country. There was significant geographic variability with a higher prevalence of IgG/IgM antibodies to SARS-CoV-2 in rural areas.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2COVID-19AdultMaleHumansFemaleAgedMiddle AgedCross-Sectional StudiesKazakhstanSeroepidemiologic StudiesImmunoglobulin GImmunoglobulin MAntibodies, Viral

Stichwörter der Autor:innen

COVID‐19SARS‐CoV‐2antibodiesasymptomaticseroprevalence

Substanzen

Immunoglobulin GImmunoglobulin MAntibodies, Viral

Autor:innen und Institutionen

  • B. Atchabarov Scientific-Research Institute of Fundamental and Applied Medicine, S.D. Asfendiyarov Kazakh National Medical University, Almaty, Republic of Kazakhstan.
  • Department of Public Health, Public Opinion Research Centre, Almaty, Republic of Kazakhstan.
  • Faculty of Medicine and Healthcare, Al-Farabi Kazakh National University, Almaty, Republic of Kazakhstan.
  • Department of Chemistry and Biology, Nazarbayev Intellectual School of Chemistry and Biology, Shymkent, Republic of Kazakhstan.

ORCID-Profile: Ildar Fakhradiyev

Zitieren

APA

Kulimbet, M., Saliev, T., Alimbekova, G., Ospanova, D., Tobzhanova, K., Tanabayeva, D., Zhussupov, B., & Fakhradiyev, I. (2023). Study of seroprevalence of SARS‐CoV‐2 in Kazakhstan. Epidemiology and Infection. https://doi.org/10.1017/s0950268823001085

Vancouver

Kulimbet M, Saliev T, Alimbekova G, Ospanova D, Tobzhanova K, Tanabayeva D, et al. Study of seroprevalence of SARS‐CoV‐2 in Kazakhstan. Epidemiology and Infection. 2023. doi:10.1017/s0950268823001085

BibTeX
@article{Kulimbet2023,
  author = {Kulimbet, Mukhtar and Saliev, Timur and Alimbekova, Gulzhan and Ospanova, Dinara and Tobzhanova, Kundyzay and Tanabayeva, Dariga and Zhussupov, Baurzhan and Fakhradiyev, Ildar},
  title = {Study of seroprevalence of SARS‐CoV‐2 in Kazakhstan},
  journal = {Epidemiology and Infection},
  year = {2023},
  doi = {10.1017/s0950268823001085}
}
Kostenlos starten →